GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹21 Cr | ₹16 Cr | ₹22 Cr | ₹13 Cr | ₹75 Cr |
What is the latest Contingent Liabilities ratio of GLAND PHARMA ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹21 Cr |
Mar2024 | ₹16 Cr |
Mar2023 | ₹22 Cr |
Mar2022 | ₹13 Cr |
Mar2021 | ₹75 Cr |
How is Contingent Liabilities of GLAND PHARMA Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹21 Cr | 37.24 | |
Mar2024 | ₹16 Cr | -29.41 | |
Mar2023 | ₹22 Cr | 72.94 | |
Mar2022 | ₹13 Cr | -82.91 | |
Mar2021 | ₹75 Cr | - |
Compare Contingent Liabilities of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹32,617.2 Cr | -3.5% | 5.6% | -3.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,864.0 Cr | -4.3% | -3% | -0.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹168,811.0 Cr | -3.3% | -7.4% | 34.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,352.0 Cr | 1.4% | 10.1% | 17.9% | Stock Analytics | |
CIPLA | ₹121,260.0 Cr | -4.4% | -0.5% | 0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,786.0 Cr | -5.2% | -5.7% | -5.9% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | -3.5% |
5.6% |
-3.6% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses